AGENUS INC (AGEN)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Latest AGEN Insider Trades
Garo H. Armen - OfficerGrant or award1,971,500 sh
Garo H. Armen - Officer
Thomas L. Harrison - Director
Timothy Wright - Director
Jennifer Buell - OfficerGaro H. Armen - OfficerAgenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 13 | 2,552,100 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
83 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Garo H. Armen - Officer | Grant or award | Common Stock | 4,769 | $3.43 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 4,700 | $3.48 | $16K | |
| Jennifer Buell | Grant or award | Common Stock | 581 | $3.11 | $2K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 5,260 | $3.11 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 7,886 | $2.08 | $16K | |
| Jennifer Buell | Grant or award | Common Stock | 869 | $2.08 | $2K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 10,288 | $1.56 | $16K | |
| Jennifer Buell | Grant or award | Common Stock | 1,159 | $1.56 | $2K | |
| Thomas L. Harrison | Grant or award | Common Stock | 8,898 | $2.88 | $26K | |
| Timothy Wright | Grant or award | Deferred Stock Units | 3,256 | - | - | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 5,931 | $2.75 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 5,347 | $3.05 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 4,769 | $3.42 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 5,997 | $2.72 | $16K | |
| Garo H. Armen - Officer | Grant or award | Stock Option | 600,000 | $0.00 | - | |
| Jennifer Buell - Officer | Grant or award | Stock Option | 300,000 | $0.00 | - | |
| Christine M. Klaskin - Officer | Grant or award | Stock Option | 10,000 | $0.00 | - | |
| Steven J. O'Day - Officer | Grant or award | Stock Option | 50,000 | $0.00 | - | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 4,207 | $4.05 | $17K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 3,530 | $4.62 | $16K | |
| Garo H. Armen - Officer | Grant or award | Common Stock | 3,349 | $4.87 | $16K | |
 Ulf Wiinberg | Grant or award | Deferred Stock Units | 3,423 | - | - | |
| Susan B. Hirsch | Grant or award | Deferred Stock Units | 3,173 | - | - | |
| Timothy Wright | Grant or award | Deferred Stock Units | 1,252 | - | - |
This is as far as the anonymous view goes. Create a free account for all 83 AGEN filings on record.
AGENUS INC (AGEN) had 13 insider filings in the last 90 days, with the most recent on 2026-08-13. The full record for AGEN runs to 83 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AGEN were filed in the last 90 days.
No insider sales of AGEN were filed in the last 90 days.
This page tracks AGEN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AGEN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
